Related references
Note: Only part of the references are listed.Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Clinical impact of pancreaticoduodenectomy for pancreatic cancer with resection of the secondary or later branches of the superior mesenteric vein
Masayuki Honda et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2020)
Benign Portal Vein Stenosis After Pancreaticoduodenectomy
Katsuhisa Ohgi et al.
WORLD JOURNAL OF SURGERY (2019)
Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery
Yuichi Nagakawa et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
Fuyuhiko Motoi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
Surgical Outcomes of Pancreaticoduodenectomy for Pancreatic Cancer with Proximal Dorsal Jejunal Vein Involvement
Yuichi Hosokawa et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Approaching the superior mesenteric artery from the right side using the proximal-dorsal jejunal vein preisolation method during laparoscopic pancreaticoduodenectomy
Yuichi Nagakawa et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2018)
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
Thomas J. Ettrich et al.
BMC CANCER (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Surgical pitfalls of jejunal vein anatomy in pancreaticoduodenectomy
Yoshiya Ishikawa et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2017)
A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement
Yuichi Nagakawa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma
F. Giovinazzo et al.
BRITISH JOURNAL OF SURGERY (2016)
Locally Advanced Pancreatic Cancer Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients
Thilo Hackert et al.
ANNALS OF SURGERY (2016)
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka et al.
LANCET (2016)
Pancreatic Adenocarcinoma with Venous Involvement: Is Up-Front Synchronous Portal-Superior Mesenteric Vein Resection Still Justified? A Survey of the Association Fran‡aise de Chirurgie
Jean Robert Delpero et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma
Y. Murakami et al.
BRITISH JOURNAL OF SURGERY (2015)
Perioperative and Long-Term Outcome after Standard Pancreaticoduodenectomy, Additional Portal Vein and Multivisceral Resection for Pancreatic Head Cancer
Birte Kulemann et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Portal vein patency after pancreatoduodenectomy for periampullary cancer
M. J. Kang et al.
BRITISH JOURNAL OF SURGERY (2015)
Portal Vein Resection in Borderline Resectable Pancreatic Cancer: A United Kingdom Multicenter Study
Reena Ravikumar et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Indication for the use of an interposed graft during portal vein and/or superior mesenteric vein reconstruction in pancreatic resection based on perioperative outcomes
Seiko Hirono et al.
LANGENBECKS ARCHIVES OF SURGERY (2014)
Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
Maximilian Bockhorn et al.
SURGERY (2014)
First jejunal vein oriented mesenteric excision for pancreatoduodenectomy
Masafumi Nakamura et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Extended Pancreaticoduodenectomy with Vascular Resection for Pancreatic Cancer: A Systematic Review
Terence C. Chua et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
Ross A. Abrams et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Borderline resectable pancreatic cancer: The importance of this emerging stage of disease
Matthew H. G. Katz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Postoperative pancreatic fistula: An international study group (ISGPF) definition
C Bassi et al.
SURGERY (2005)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)